Treatment of moderate to severe cases of COVID-19 with colchicine
Phase 3
- Conditions
- Coronavirus disease 2019 (COVID-19)
- Registration Number
- RBR-10k2w2c5
- Lead Sponsor
- Hospital das Clínicas de Ribeirão Preto
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with COVID-19; over 18 years old; at least 50 kg of body weight; moderate or severe form of COVID-19; in need of treatment in a hospital environment; women between 18 and 50 years old should have a negative serum or urine test for beta human chorionic gonadotropin
Exclusion Criteria
Mild form of COVID-19; allergy to colchicine; diagnosis of porphyria, myasthenia gravis or uncontrolled arrhythmia on admission; pregnancy or lactancy; use of cyclosporine, digoxin, amiodarone, verapamil, metoprolol or protease inhibitors; history of chronic liver disease with liver dysfunction; unable to understand the information contained in the consent form.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method